2023 Annual Report Out Now

21 December 2023

Our 2023 Annual Report is out today!

In eight years of operation, MTPConnect has firmly established itself as Australia’s life sciences innovation accelerator and the team’s work during FY2023 has further contributed to outstanding outcomes for the growth of the medical technology, biotechnology and pharmaceutical sector.

Medical science is a priority for the Australian Government for driving economic transformation and MTPConnect now sits at the centre of this critical knowledge intensive sector - supporting researchers, start-ups and SMEs to turn their discoveries into home-grown and life-saving new medical products.

MTPConnect has injected $153 million into the sector, supporting 196 innovation projects across Australia. Its investment has leveraged more than $1 billion in additional industry contributions and flow-on external investment, allowing SMEs to scale-up and create new jobs.

Across all programs and initiatives, the overall economic impact of MTPConnect’s activities shows a total attributable return of ~$6.5 billion.

A focus on research commercialisation lies at the heart of our accelerator initiatives and across all our accelerator programs we’ve seen 1,585 new technologies invented or progressed, 300 new projects launched and over 740,000 patients treated.

MTPConnect’s work shows what can be achieved by backing start-ups, entrepreneurs and SMEs to bring new medical products from research labs to the market.

With a solid track record of success as Australia’s life sciences innovation accelerator, and strong relationships with government and industry stakeholders, we continue to explore options for future growth so we can maintain our central role in helping expand Australia’s medical products sector.

Take a look at our 2023 Annual Report to find out more about our activities and their impact during FY2023.